By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Sale of pharmaceutical products118.71M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.117.1M98.64%
Royalty revenue1.61M1.36%